Daniel Dalos

Medical University of Vienna — Austria

Medicine · Health Sciences

17h-index859citations78works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Function and Risk Factors(28), Amyloidosis: Diagnosis, Treatment, Outcomes(18), Coronary Interventions and Diagnostics(14), Heart Failure Treatment and Management(12), Cardiac Imaging and Diagnostics(11)

Publications77 total

Sex-Specific Differences in Patients with Hypertrophic Cardiomyopathy: A Cohort Study from Vienna
Journal of Personalized Medicine·2026Open Access
Left atrial mechanics and the risk of atrial fibrillation in patients with hypertrophic cardiomyopathy
European Heart Journal·2025
The Prognostic Implication of Late Gadolinium Enhancement Quantification and Syncope in Hypertrophic Cardiomyopathy
Journal of Clinical Medicine·2025· 2 citedOpen Access
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy
Wiener klinische Wochenschrift·2024· 3 citedOpen Access
Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes
European Heart Journal·2024Open Access
Gender-related differences in clinical characteristics of patients with hypertrophic cardiomyopathy in our city
European Heart Journal·2024
Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis—Insights from Histology and Cardiac Magnetic Resonance Imaging
Journal of Clinical Medicine·2024· 8 citedOpen Access
Association between scar quantification and documented history of ventricular tachycardia in patients with hypertrophic cardiomyopathy
European Heart Journal·2023Open Access
Coronary artery disease in cardiac amyloidosis
European Heart Journal·2023Open Access
Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registry
European Heart Journal - Cardiovascular Imaging·2023· 22 citedOpen Access
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy
European Heart Journal - Cardiovascular Imaging·2023· 61 citedOpen Access
VALIDATION OF AN ELECTROCARDIOGRAPHIC ALGORITHM FOR THE DETECTION OF CARDIAC AMYLOIDOSIS
Journal of the American College of Cardiology·2023
Cardiac amyloidosis: a significant blind spot of the H2FPEF score
Panminerva Medica·2023· 1 citedOpen Access
Abstract 13069: Left Atrial Mechanics in Patients With Hypertrophic Cardiomyopathy
Circulation·2022
Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
Frontiers in Cardiovascular Medicine·2022· 5 citedOpen Access
Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy
Amyloid·2022· 27 cited
The impact of left atrial mechanics on adverse events and clinical outcome after cardiac surgery
European Heart Journal·2022Open Access
Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?
European Heart Journal·2022Open Access
Validation of an electrocardiographic algorithm for the detection of cardiac amyloidosis
European Heart Journal·2022· 1 citedOpen Access
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
European Heart Journal·2022· 66 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Franz Duca(28), Diana Bonderman(22), Theresa-Marie Dachs(19), René Rettl(18), Lore Schrutka(17), Christian Hengstenberg(17), Johannes Kästner(16), Andreas A. Kammerlander(15), Christina Binder(13), Julia Mascherbauer(12), Stefan Aschauer(11), Luciana Camuz Ligios(9), R Badr-Eslam(9), Benjamin Seirer(9), Caroline Zotter‐Tufaro(8), Dietrich Beitzke(8), Christian Loewe(8), Roza Badr Eslam(8), Clemens Gangl(8), Thomas Neunteufl(7)